ArticleJournal of translational medicine2025

15,16-Dihydrotanshinone I, a novel β-catenin-targeting inhibitor that inhibits its nuclear translocation and reduces downstream CD36 expression in cancer.

Minting Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.